Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide, affecting more than 5 million Americans today, and projected to increase to 12.1 million in 2030. AF is associated with increased cardiovascular morbidity, including stroke, myocardial infarction, thromboembolism, and heart failure, as well as increased mortality. Physicians and all healthcare professionals managing patients with AF need to be aware of recent clinical practice guidelines for AF management, as well as any emerging data for cardiovascular (CV) outcomes related to the use of anti-arrhythmic drugs (AADs) when used in a clinical practice setting. Join our panel of top experts for an interactive, virtual, CME-certified symposium focused on the latest evidence and guidelines for the use of early rhythm control in patients with recent AF to improve CV outcomes.
Faculty
Jonathan P. Piccini, MD, MHS
MODERATOR
Associate Professor of Medicine Director, Cardiac Electrophysiology Duke University Medical Center Duke Clinical Research Institute Durham, North Carolina
James A. Reiffel, MD
PANELIST
Professor Emeritus of Medicine Columbia University New York, New York
Muthiah Vaduganathan, MD, MPH
PANELIST
Attending Cardiologist Division of Cardiovascular Medicine Brigham and Women’s Hospital Instructor of Medicine Harvard Medical School Boston, Massachusetts
Agenda MONDAY, NOVEMBER 15, 2021
5:00 PM - 6:30 PM
Welcome and Introductions by Chairperson
Presentations:
Patient Journeys: Virtual Patients With AF
Rhythm Control in AF: Where Are We Today?
Bringing It Back to the Patient: Practical Strategies to Improve Detection and Rhythm Control
